Minerva Neurosciences
NERV • NASDAQ
Minerva Neurosciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Remy Luthringer, with a market cap of $260.5M.
Market Cap$260.5M
Employees9.0
CEORemy Luthringer
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · in a monthQ1 2026
Financials
NER
Minerva Neurosciences FAQ
Common questions about Minerva Neurosciences
Minerva Neurosciences is scheduled to report earnings for Q1 2026 on May 12, 2026.
Minerva Neurosciences has approximately 9 employees.